Medacta Group revenue and financials
CHF 114.60Change from previous close: 0.00%
In the fiscal year ended December 2025, Medacta Group reported revenue of €683.83M (+15.79% year over year). Net income was €95.46M, a net margin of 14.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +15.79%
- 2025 vs 2024
- Net income growth
- +30.97%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 12.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 684 | 591 | 511 | 437 | — |
| Cost of revenue | 225 | 191 | 163 | 132 | — |
| Gross profit | 459 | 399 | 348 | 305 | — |
| Selling, general and administrative | 262 | 232 | 206 | 180 | — |
| Research and development | 23.5 | 21.4 | 20.3 | 16.2 | — |
| Operating income | 111 | 90.8 | 74.4 | 61.5 | — |
| EBIT | 122 | 95.3 | 65.6 | 58.5 | — |
| EBITDA | 197 | 161 | 123 | 109 | — |
| Interest expense | 6.8 | 7.5 | 6.8 | 3.7 | — |
| Pre-tax income | 115 | 87.8 | 58.7 | 54.8 | — |
| Income tax | 19.8 | 14.9 | 11.4 | 8.5 | — |
| Net income | 95.5 | 72.9 | 47.4 | 46.2 | — |
| Net income to common shareholders | 95.5 | 72.9 | 47.4 | 46.2 | — |
| Basic EPS | — | 3.66 | 2.37 | 2.32 | 2.58 |
| Diluted EPS | — | 3.65 | 2.37 | 2.31 | 2.58 |
| Average shares (basic) | — | 19.9 | 20.0 | 20.0 | 20.0 |
| Average shares (diluted) | — | 20.0 | 20.0 | 20.0 | 20.0 |